2001, Chemotherapy and Drug Development

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

Chemotherapy

Drug Development

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6% Mei says that oncology is one of the key region-specific unmet medical needs Antengene is hoping to address with innovative drugs.

Chemotherapy

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunity

PROTAC development gains momentum, but clinical performance is poor

Pharmaceutical Technology

FEBRUARY 13, 2023

The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality. By this same virtue, PROTACs are able to degrade previously undruggable targets, which provides a major competitive advantage for this modality if shown to be true.

Dosage

Dosage Chemotherapy Compounding Immunity

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Pharmacist Digest

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

PROTAC development gains momentum, but clinical performance is poor

Webinars

Stay Connected